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Abstract. In late 2014, Zika virus (ZIKV; Flaviviridae, Flavivirus) emerged as a significant arboviral disease threat
in the Western hemisphere. Aedes aegypti and Aedes albopictus have been considered the principal vectors of ZIKV
in the New World due to viral isolation frequency and vector competence assessments. Limited reports of Culex
transmission potential have highlighted the need for additional vector competence assessments of North American
Culex species. Accordingly, North American Culex pipiens and Culex quinquefasciatus were orally exposed and
intrathoracically inoculated with the African prototype ZIKV strain and currently circulating Asian lineage ZIKV strains
to assess infection, dissemination, and transmission potential. Results indicated that these two North American
Culex mosquito species were highly refractory to oral infection with no dissemination or transmission observed with
any ZIKV strains assessed. Furthermore, both Culex mosquito species intrathoracically inoculated with either Asian
or African lineage ZIKVs failed to expectorate virus in saliva. These in vivo results were further supported by the
observation that multiple mosquito cell lines of Culex species origin demonstrated significant growth restriction of
ZIKV strains compared with Aedes-derived cell lines. In summation, no evidence for the potential of Cx. pipiens or
Cx. quinquefasciatus to serve as a competent vector for ZIKV transmission in North America was observed.
INTRODUCTION
Zika virus (ZIKV), a member of the genus Flavivirus, has
recently surfaced as a significant threat to global public
health despite only having been found in the Western hemi-
sphere since late 2014. The first ZIKV isolates were made
from a sentinel Rhesus monkey and subsequently from
arboreal Aedes africanus mosquitoes, a suspected sylvatic
cycle vector,1 in Uganda in 1947 and 1948.2 The first
described clinical case was identified in Nigeria in 1954 in
which the individual exhibited symptoms similar to many
arthralgic arboviruses including fever, headache, diffuse
joint pain, and slight jaundice.3 Serological evidence of
ZIKV infection was subsequently identified in Nigeria,
Egypt, India, Malaysia, Indonesia, Philippines, Thailand,
Vietnam, and Senegal.4–11 Phylogenetic analysis demon-
strates three distinct ZIKV genotypes corresponding to the
initial emergence in east Africa and subsequent spread to
west Africa and Asia.12 ZIKV was associated with sporadic
limited human disease prior to 2007 when ZIKV caused out-
breaks in Yap and Gabon.13,14 By 2013, ZIKV had spread
to French Polynesia and other islands of the South Pacific
including New Caledonia, the Cook Islands, and Easter
Island prior to its first detection in the Western hemisphere
in 2014.15
First detected in the peridomestic vector, Aedes aegypti,
in Malaysia in 1966,16 subsequent vector competence and
ecological studies have established ZIKV to be vectored
primarily by members of the genus Aedes in both sylvatic
and urban cycles through field studies.2,16–24 However,
recent ZIKV detection in Culex mosquitoes25,26 and reports
of experimental evidence of transmission of ZIKV by Culex
quinquefasciatus,26,27 have raised public concerns that
mosquitoes of the Culex pipiens complex could play a role
in transmission as well. Vector competence by mosquitoes
of alternative genera would have possible implications for
many regions of North America where the known Aedes
vectors, Ae. aegypti and Aedes albopictus, are absent and
a significant number of Culex species are present. The utili-
zation of both Aedes and Culex mosquitoes as vectors
would alter the discourse and strategy for control efforts.
Surveillance and control of Culex mosquitoes requires utili-
zation of different tools and greatly increases the area of
surveillance based on the wide geographic range of poten-
tial Culex vectors.
There have been a number of recent studies directly eval-
uating the vector competence of Culex mosquitoes for cir-
culating strains of ZIKV and the results have been mixed.
Two studies using Cx. pipiens and Cx. quinquefasciatus
from North America showed a lack of ZIKV infection, dis-
semination, or saliva infection after oral exposure by artifi-
cial or viremic mice as blood meal sources.28,29 A study
from Brazil showed a low level of experimental infection in
Cx. quinquefasciatus after artificial blood meal exposure,
but no dissemination from the midgut or transmission.30 An
Italian study indicated a lack of infection in Cx. pipiens
mosquitoes after oral exposure,31 whereas a second study
in Europe examining ZIKV oral infection of Cx. pipiens and
Cx. quinquefasciatus found evidence of infection and low
rates of dissemination but no transmission.32 The findings
from experiments described above are in direct contrast
with two reports of highly efficient transmission potential
from Brazil26 and China.27 In an attempt to rule out the
role of Culex mosquitoes as possible ZIKV vectors in
North America, we evaluated Cx. quinquefasciatus and Cx.
pipiens mosquitoes for susceptibility to infection after oral
and intrathoracic (IT) exposure to recent Asian genotype
ZIKV isolates from Puerto Rico and Honduras as well as the
original African lineage isolate from Uganda. Additionally,
we compared the growth capacity of each virus in model
Aedes and Culex cell lines to highlight the lack of replication
competence of ZIKV for in vitro and in vivo Culex models.
*Address correspondence to Joan L. Kenney, Centers for Disease
Control and Prevention, Fort Collins, CO 80521. E-mail: vwx1@
cdc.gov
†These authors contributed equally to this work.
1235
MATERIALS AND METHODS
Viruses and mosquitoes. ZIKV isolates MR766 (Uganda
1947), PRVABC59 (Puerto Rico 2015), and R103451
(Honduras 2016) were used for mosquito infections in this
study. The MR766 strain had a history of 149 passages in
unknown sources, including suckling mouse brain, and two
known passages in African green monkey kidney (Vero) epi-
thelial cells. PRVABC59 was isolated from the serum of a
febrile traveler returning to the continental United States
from Puerto Rico in 2015 and was passaged three times
in Vero cells.33 The R103451 isolate was derived from
a human placenta from a patient who had traveled to
Honduras in 2015 and passaged in C6/36 mosquito cells
once. Colonized Cx. quinquefasciatus (Sebring) and Cx.
pipiens pipiens (Chicago) were used for in vivo exposure
experiments. The colony of Cx. quinquefasciatus was origi-
nally established in Florida in 1988 and has since been
maintained at the Centers for Disease Control and Preven-
tion in Fort Collins, CO, since 2004.34 The original Cx.
pipiens were collected in Chicago as mated, overwintering
females in 2010 and distinguished from Cx. pipiens form
molestus through microsatellite testing.35
Oral mosquito infections. For each exposure dose
of each virus, cohorts of 5- to 6-day-old female Cx.
quinquefasciatus and Cx. pipiens were orally exposed to
individual ZIKV strain containing blood meals through an
artificial Hemotek membrane feeder (Discovery Workshops,
Accrington, United Kingdom). Frozen stocks of known titers
were thawed and used for blood meal exposure. For Cx.
quinquefasciatus, two cohorts of 50 adult females were
exposed to the same dose of MR766 (6.0 log10 plaque-
forming units [PFU]/mL); three cohorts were exposed to
4.0, 5.9, and 7.1 log10 (PFU/mL) of PRVABC59; and two
cohorts were exposed to 6.4 and 7.6 log10 (PFU/mL) of
R103451. For orally exposed Cx. pipiens, one cohort each
was exposed to 6.0 log10 (PFU/mL) of MR766 and
PRVABC59. Female mosquitoes were allowed to feed for
45 minutes on the heated artificial blood meals containing
33% (v/v) defibrinated goose (Cx. pipiens) or calf (Cx.
quinquefasciatus) washed erythrocytes (Colorado Serum
Company, Denver, CO), 33% (v/v) heat-inactivated fetal
bovine serum (FBS) (Omega Scientific, Inc., Tarzana, CA),
33% (v/v) of each individual virus in cell culture fluid
(resulting in a final concentration ranging from 4.0 to 7.1
log10 PFU/mL) and 1% (v/v) of 0.25 μM adenosine triphos-
phate (Table 1). After blood feeding, mosquitoes were
cold-anesthetized for sorting, and engorged females were
held at 28°C with a relative humidity of 70–75% for an
extrinsic incubation period of 14 days.
Mosquito processing and testing. At the conclusion of
the 14-day extrinsic incubation period, mosquitoes were
anesthetized with triethylamine (Flynap®; Carolina Biological
Supply company, Burlington, NC) as previously described.36
Salivations were performed by insertion of the proboscis
of each immobilized mosquito into a 10-μL capillary tube
containing immersion oil (Cargille Laboratories, Cedar Grove,
NJ) to induce salivation for approximately 45 minutes. Legs
and wings were removed from anesthetized mosquitoes and
placed in microcentrifuge tubes with 500 μL of complete
media composed of Dulbecco’s modified Eagle’s essential
medium (DMEM) complete with penicillin (100 U/mL), strep-
tomycin (100 mg/mL), 10% FBS, amphotericin B (50μg/mL),
and a sterile copper bead. After salivation, bodies and sali-
vary capillary tubes were separated into 1.5-mL tubes with
500 μL and 350 μL of complete media, respectively. Sam-
ples with mosquito bodies and legs/wings were each tritu-
rated for 4 minutes at a frequency of 26 cycles per second
using a Mixer Mill 300 (Retsch, Newton, PA). Samples
containing salivary capillary tubes were centrifuged to clarify
supernatants. Each sample was tested for cytopathic effects
(CPEs) on Vero cells as previously described.37 Collected
salivary material for a given sample was not tested if dissem-
ination was not detected.
IT mosquito infections. Cohorts of 50 adult female Cx.
quinquefasciatus, Cx. pipiens, and Ae. aegypti colonized
from Poza Rica, Mexico,38 were subjected to IT inoculation
of approximately 300 PFU (0.33 μL inoculation of 6 log10
[PFU/mL]) of PRVABC59 or MR766 ZIKV. Mosquitoes were
held for an extrinsic incubation period of 7 days at 28°C
with a relative humidity of 70–75%. Mosquitoes were
processed as described above. After processing, bodies
and saliva samples were stored at −80°C until titration for
virus by plaque assay or viral RNA testing. CPE-negative
saliva from intrathoracically inoculated mosquitoes was
subsequently analyzed by real-time reverse transcription
polymerase chain reaction (qRT-PCR)39 to confirm negative
results. Viral RNA was extracted using the QIAamp Viral
RNA Mini Kit (Qiagen, Valencia, CA) according to the manu-
facturer’s protocol.
In vitro growth on Culex cell lines. Replication profiles
were assessed on Ae. aegypti (Aag-2), Ae. albopictus (C6/36),
Cx. quinquefasciatus cells (Hsu), and Culex tarsalis
(CT)–derived cell lines. All cell lines were propagated in
TABLE 1
Infection, dissemination, and transmission rates after CPE analysis at 14 days postexposure in Culex quinquefasciatus and Culex pipiens
orally exposed to infectious blood meals with strains of ZIKV
Species Virus N Blood meal titer (PFU/mL) log10 Infection (%) Dissemination (%)*
Culex quinquefasciatus MR766 95 6 1 (1) 0 (0)
PRVABC59 36 7.1 0 (0) 0 (0)
48 5.9 0 (0) 0 (0)
43 4 0 (0) 0 (0)
R103451 35 7.6 0 (0) 0 (0)
30 6.4 0 (0) 0 (0)
Culex pipiens pipiens MR766 20 6 1 (5) 0 (0)
PRVABC59 38 6 4 (10) 0 (0)
CPE = cytopathic effect; PFU = plaque-forming units; ZIKV = Zika virus. MR766 was isolated from Uganda in 1947, PRVABC59 was isolated from Puerto Rico in 2015, and R103451 was
isolated from Honduras in 2016.
*Saliva samples not tested for transmission in the absence of dissemination.
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DMEM supplemented with 5% FBS, penicillin (100 U/mL),
and streptomycin (100 mg/mL). Cells were grown to 90%
confluency in 6-well plates, and monolayers were infected
in triplicate at a multiplicity of infection (MOI) of 0.1 PFU/
cell. 50-μL aliquots of supernatant were collected daily,
followed by plaque assays to measure viral yield. Plaque
assays used serial 10-fold dilutions of virus seeded onto
6-well plates containing monolayers of Vero cells, as previ-
ously described.37 To compare the viral replication curves,
a two-way analysis of variance (ANOVA) test with repeated
measures and post hoc multiple comparisons test with
a Tukey correction was performed, version 6.0h (Prism
Graphpad Software, La Jolla, CA). P values < 0.05 were
considered significant.
RESULTS
Oral infection, dissemination, and transmission in
Culex mosquitoes. Oral infection rates were low for both
Cx. quinquefasciatus (0–1%) and Cx. pipiens (1–10%)
regardless of the virus used (Table 1). For example, only 1/95
Cx. quinquefasciatus was identified to be infected after oral
exposure with 6.0 log10 PFU/mL of MR766. Similarly, no
infected Cx. quinquefasciatus mosquitoes were observed
after oral exposure to PRVABC59 with doses ranging from
4.0 to 7.1 log10 (PFU/mL) or to R103451 with doses of either
6.4 or 7.6 log10 (PFU/mL) (Table 1). There was no detectable
dissemination of virus from the midgut of the single Cx.
quinquefasciatus mosquito body identified to be ZIKV posi-
tive after oral exposure to MR766 as determined by CPE
testing of legs/wings. For Cx. pipiens, 1/20 (5%) and
4/38 (11%) were found to have detectable virus in their
bodies after exposure to 6.0 log10 (PFU/mL) of MR766 or
PRVABC59, respectively (Table 1). It should be noted that
the four positive Cx. pipiens mosquitoes only had one plaque
per well after undiluted inoculation of Vero cells, indicating
an approximate concentration of 3 PFU/mosquito body.
None of these Cx. pipiens were identified to have a dis-
seminated infection as defined by the presence of virus in
legs/wings.
Infection and transmission of inoculated mosquitoes. To
determine whether Cx. pipiens and Cx. quinquefasciatus
have the capability to transmit regardless of their apparent
inability to establish infection of the midgut and disseminate
virus, IT inoculations were performed to bypass the midgut
infection and escape barriers. This allowed for direct
assessment of ZIKV to infect the salivary glands and sub-
sequently be transmitted during salivation. Seven days
after IT inoculation, 16/23 (70%) and 5/33 (15%) Cx.
quinquefasciatus bodies were identified to be positive for
MR766 and PRVABC59 viruses, respectively (Table 2).
Plaque assay and subsequent qRT-PCR showed no virus
or viral RNA–positive saliva samples. Experiments on
Cx. pipiens provided similar results with 17/28 (61%) tritu-
rated bodies demonstrating virus 7 days after inoculation
with PRVABC59 (Table 2), yet no evidence of transmissibility
was observed by plaque assay or qRT-PCR assessments of
expectorants. In contrast, evaluation of the IT susceptibility
of Ae. aegypti showed that 12/12 (100%) of the surviving
mosquitoes became infected after inoculation and 8/12
(67%) of infected mosquitoes demonstrated the presence of
virus in salivary material indicating transmission potential.
In vitro growth of ZIKV strains in Aedes and Culex
mosquito cells. Culex quinquefasciatus, Cx. tarsalis, Ae.
aegypti, and Ae. albopictus cell lines were each inoculated
at an MOI of 0.1 PFU/cell with PRVABC59 and MR766 and
sampled daily for 7 days. A two-way repeated measures
ANOVA for each virus demonstrated a significantly different
level of growth between the three types of mosquito cells
(P < 0.0001) (Figure 1). PRVABC59 reached a mean peak
titer of 8.5 log10 (PFU/mL) on day postinoculation (dpi)
TABLE 2
Detection of infection and transmission rates by CPE testing in Culex quinquefasciatus and Culex pipiens intrathoracically inoculated with ZIKV
Species Virus N Inoculum stock (PFU/mL)log10 Infection (%) Transmission (%)*
Culex quinquefasciatus MR766 23 6.7 16 (70) 0 (0)
PRVABC59 33 6 5 (15) 0 (0)
Culex pipiens pipiens PRVABC59 28 6 17 (61) 0 (0)
Aedes aegypti PRVABC59 12 6 12 (100) 8 (67)
CPE = cytopathic effect; PFU = plaque-forming units; ZIKV = Zika virus. MR766 was isolated from Uganda in 1947, PRVABC59 was isolated from Puerto Rico in 2015, and R103451 was
isolated from Honduras in 2016.
*CPE-negative saliva samples were confirmed by reverse transcription polymerase chain reaction.
FIGURE 1. Zika virus (ZIKV) growth in mosquito cells. Compari-
son of (A) PRABCV59 and (B) MR766 replication in Aedes aegypti
(Aag-2), Aedes albopictus (C6/36), Culex quinquefasciatus (Hsu),
and Culex tarsalis (CT) cells. LOD = limit of detection. Error bars
represent standard deviations.
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7 and 7.5 log10 (PFU/mL) on dpi 6 for Ae. albopictus and
Ae. aegypti cells, respectively. The Puerto Rico virus titer in
both Culex cell lines was highest on the initial sampling
point at 0 dpi and dropped over the time course, indicating
a growth rate below the loss of viral infectivity in the cul-
tures over time. As such, mean titers of PRVABC59 growth
in Ae. albopictus cells and Ae. aegypti were significantly
higher (P < 0.0001) than either Culex cell line (Figure 1A).
Similarly, MR766 reached a mean peak titer of 7.8 log10
(PFU/mL) on dpi 7 and 7.4 log10 (PFU/mL) on dpi 6 in Ae.
albopictus and Ae. aegypti cells. Subsequent multiple com-
parison testing of MR766 demonstrated growth reached
significantly higher mean viral titers (P < 0.0001) on Ae.
albopictus and Ae. aegypti cells as compared with each of
the Culex cell lines, as viral titers continued to drop for
these two cell lines from dpi 0–7 and never appeared to
grow (Figure 1B).
DISCUSSION
The potential vector competence of Cx. pipiens and Cx.
quinquefasciatus was evaluated after oral and IT exposure
of multiple ZIKV strains at a range of doses. Only a small
percentage of mosquitoes were susceptible to infection
orally (up to 10% for Cx. pipiens) and a range of 15–70% of
intrathoracically inoculated mosquitoes demonstrated virus-
positive bodies. However, unlike what was observed after
IT inoculation of Ae. aegypti mosquitoes, there was no
observed dissemination in any of the orally exposed Culex
mosquitoes or salivary infection in any of the 38 intra-
thoracically inoculated mosquitoes showing body infection.
The lack of detectable viral RNA or infectious virus in saliva,
despite obviation of the midgut infection/escape barriers
through IT inoculation, strongly suggests that ZIKV is inca-
pable of infection of the salivary glands and/or entering
the salivary fluids of Cx. quinquefasciatus and Cx. pipiens.
Further, in vitro experiments demonstrate that ZIKV was
unable to replicate in Culex cell lines.
The conclusions reported here regarding the inability
of Culex mosquitoes to vector ZIKV correspond with a
majority of recent studies addressing ZIKV transmission
in Culex mosquitoes.28–32 In contrast, two accounts report
differing ZIKV transmission potential of Culex mosquitoes.
The first case is a summary of findings presented during
a ZIKV workshop in Brazil in 2016 in which the authors
report detection of virus from the salivary glands of Cx.
quinquefasciatus at 7 and 15 days postexposure.26 To date,
that presented data has not been formally published. How-
ever, a published study using several Brazilian ZIKV iso-
lates with locally established Culex mosquito populations
demonstrated incompetence of Cx. quinquefasciatus from
Rio de Janeiro for infection, dissemination, and trans-
mission.30 Guo and others orally exposed colonized Cx.
quinquefasciatus from the Hainan Province of China with a
low passage strain isolated from a traveler returning from
Samoa (GenBank: KU866423). In this report, 8/10 (80%)
saliva samples demonstrated the presence of ZIKV RNA
by RT-PCR 8 days after exposure, with the ZIKV RNA posi-
tivity rate in saliva dropping at later time points.27 These
results could indicate the possibility of differential suscep-
tibility between Asian and American populations of Cx.
quinquefasciatus. However, the incongruous comparison
between detection of infectious virus, as traditionally mea-
sured by plaque formation or CPE assay, to RNA detection
precludes drawing definitive conclusions between the
two studies.
Phylogenetic analysis of mosquito-borne flaviviruses
(MBFV) have long shown two distinct clades, one of which
is primarily associated with Aedes mosquitoes with the
other associated with Culex vectors.40,41 For instance,
dengue-1, 2, 3, and 4 viruses are transmitted by Ae. aegypti
mosquitoes, but not Culex mosquitoes.42 Considering the
evolutionary precedent of MBFV steadfast adherence to
being vectored by either Aedes or Culex mosquitoes but
not both, it would be consistent that ZIKV would be vec-
tored by Aedes mosquitoes. Similarly, Culex-borne flavi-
viruses typically use avian amplification hosts. Transmission
of ZIKV to humans by Culex mosquitoes would require rep-
lication to high titers in avian hosts and potential epizootic
spillover into humans as the Culex mosquitoes of concern
primarily feed on avians and less frequently on humans.
Blood meal analysis studies typically show humans to be a
source of 0–2% of all blood meals taken by North American
Cx. pipiens, Cx. quinquefasciatus, and Cx. tarsalis mosqui-
toes.43–50 Lack of suitable ZIKV avian hosts combined
with low human blood feeding rates for Culex mosquitoes
diminish the potential role of Culex mosquitoes as vectors
regardless of their vector competence for ZIKV.
Our use of oral and IT exposure in Cx. pipiens and Cx.
quinquefasciatus to show the inability of ZIKV to dissemi-
nate to the salivary glands in addition to the lack of
observed ZIKV replication in Culex cell lines, strongly indi-
cates that these North American Culex mosquitoes are not
competent vectors of ZIKV. In conjunction with previously
mentioned ecological requirements of utilizing Culex mos-
quitoes as vectors, we conclude that there is no evidence
to support Culex mosquito monitoring or management with
regard to ZIKV control efforts.
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